XML 106 R74.htm IDEA: XBRL DOCUMENT v3.19.1
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Numerator:    
Net income attributable to Biogen Inc. $ 1,408.8 $ 1,172.9
Weighted-average shares used in calculating:    
Weighted average number of common shares outstanding 196.6 211.4
Effect of dilutive securities:    
Dilutive potential common shares 0.4 0.3
Shares used in calculating diluted earnings per share 197.0 211.7
Stock options and employee stock purchase plan    
Effect of dilutive securities:    
Stock units 0.0 0.0
Time-vested restricted stock units    
Effect of dilutive securities:    
Stock units 0.3 0.2
Market stock units    
Effect of dilutive securities:    
Stock units 0.1 0.1
Performance stock units settled in stock    
Effect of dilutive securities:    
Stock units 0.0 0.0